TARO PHARMACEUTICAL INDUSTRIES LTD (TARO) Financial Statements
TARO PHARMACEUTICAL INDUSTRIES LTD (TARO) files with the U.S. Securities and Exchange Commission under CIK 0000906338. 10KGenie shows its annual statements from SEC filings.
Key Figures, Fiscal Year 2023
- Revenue
- $572.95 million
- Net Income
- $25.45 million
- Total Assets
- $2.14 billion
- Net Cash from Operations
- $31.75 million
Fiscal year ended Mar 31, 2023. Latest periodic SEC filing: Jun 29, 2023. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for TARO in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History